These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7716141)
1. Intracellular degradation of the C-peptide of proinsulin, in a human insulinoma: identification of sites of cleavage and evidence for a role for cathepsin B. Conlon JM; Höög A; Grimelius L Pancreas; 1995 Mar; 10(2):167-72. PubMed ID: 7716141 [TBL] [Abstract][Full Text] [Related]
2. Sustained pulsatile insulin secretion from adenomatous human beta-cells. Synchronous cycling of insulin, C-peptide, and proinsulin. Chou HF; Ipp E; Bowsher RR; Berman N; Ezrin C; Griffiths S Diabetes; 1991 Nov; 40(11):1453-8. PubMed ID: 1936605 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic B-cells secrete a range of novel peptides besides insulin. Sopwith AM; Hales CN; Hutton JC Biochim Biophys Acta; 1984 Apr; 803(4):342-5. PubMed ID: 6322863 [TBL] [Abstract][Full Text] [Related]
4. Des-(27-31)C-peptide. A novel secretory product of the rat pancreatic beta cell produced by truncation of proinsulin connecting peptide in secretory granules. Verchere CB; Paoletta M; Neerman-Arbez M; Rose K; Irminger JC; Gingerich RL; Kahn SE; Halban PA J Biol Chem; 1996 Nov; 271(44):27475-81. PubMed ID: 8910330 [TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes. Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327 [TBL] [Abstract][Full Text] [Related]
6. A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series. Yu R; Nissen NN; Hendifar A; Tang L; Song YL; Chen YJ; Fan X Pancreas; 2017 Jan; 46(1):48-56. PubMed ID: 27984486 [TBL] [Abstract][Full Text] [Related]
7. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing. Rhodes CJ; Lincoln B; Shoelson SE J Biol Chem; 1992 Nov; 267(32):22719-27. PubMed ID: 1429623 [TBL] [Abstract][Full Text] [Related]
8. Proinsulin and C-peptide: a review. Kitabchi AE Metabolism; 1977 May; 26(5):547-87. PubMed ID: 403392 [TBL] [Abstract][Full Text] [Related]
9. The intracellular handling of insulin-related peptides in isolated pancreatic islets. Evidence for differential rates of degradation of insulin and C-peptide. Rhodes CJ; Halban PA Biochem J; 1988 Apr; 251(1):23-30. PubMed ID: 3291861 [TBL] [Abstract][Full Text] [Related]
10. Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data. Roth J; Komminoth P; Heitz PU Am J Pathol; 1995 Aug; 147(2):489-502. PubMed ID: 7639339 [TBL] [Abstract][Full Text] [Related]
11. Tumor and serum levels of proinsulin and insulin in insulinoma patients. Tasaka Y; Nakaya F; Matsumoto H; Odagiri R; Ohgawara H; Omori Y Endocr J; 1993 Apr; 40(2):245-8. PubMed ID: 7951510 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and clinical implications of proinsulin conversion intermediates. Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891 [TBL] [Abstract][Full Text] [Related]
14. In vitro conversion of proinsulin to insulin by cathepsin B and role of C-peptide. Puri RB; Anjaneyulu K; Kidwai JR; Mohan Rao VK Acta Diabetol Lat; 1978; 15(5-6):243-50. PubMed ID: 373354 [TBL] [Abstract][Full Text] [Related]
15. Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells. Won JG; Tseng HS; Yang AH; Tang KT; Jap TS; Kwok CF; Lee CH; Lin HD Metabolism; 2003 Oct; 52(10):1320-9. PubMed ID: 14564685 [TBL] [Abstract][Full Text] [Related]
16. Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity. Melles E; Jörnvall H; Tryggvason S; Danielsson KG; Ekberg K; Tryggvason K; Wahren J; Bergman T Cell Mol Life Sci; 2004 Dec; 61(23):2979-82. PubMed ID: 15583859 [TBL] [Abstract][Full Text] [Related]
17. Proinsulin processing in the regulated and the constitutive secretory pathway. Halban PA Diabetologia; 1994 Sep; 37 Suppl 2():S65-72. PubMed ID: 7821742 [TBL] [Abstract][Full Text] [Related]
18. Degradation of proinsulin and isolated C-peptide by rat kidney neutral metallo-endopeptidase. Varandani PT; Shroyer LA Biochim Biophys Acta; 1981 Oct; 661(2):182-90. PubMed ID: 7028123 [TBL] [Abstract][Full Text] [Related]
19. ANTHROPOMETRIC FEATURES ARE NOT PREDICTIVE OF 72-HOUR FAST DURATION IN INSULINOMAS. Donegan D; Jakubikova I; Vella A Endocr Pract; 2017 Aug; 23(8):923-928. PubMed ID: 28614004 [TBL] [Abstract][Full Text] [Related]
20. Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Cohen RM; Given BD; Licinio-Paixao J; Provow SA; Rue PA; Frank BH; Root MA; Polonsky KS; Tager HS; Rubenstein AH Metabolism; 1986 Dec; 35(12):1137-46. PubMed ID: 3023795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]